ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Subsequently, the cohort was stratified into low-, medium-, and high-risk groups based on their clinical characteristics at the time of initial CML diagnosis, revealing no significant associations between risk stratification, patients’ blood groups, Rh-factor, seasonality of morbidity, and ABL KD mutations.